Your browser doesn't support javascript.
loading
Effective clinical response of lung adenocarcinoma harboring EGFR 19Del/T790M/in cis-C797S osimertinib to osimertinib and gefitinib combination therapy.
Wang, Yanyan; Jiang, Chenchen; Tang, Mingyue; Li, Huiyuan; Zhao, Cancan; Zhao, Menglin; Zhang, Yue; Li, Xinwei; Mi, Jiaqi; Shen, Honghong; Wang, Zishu; Su, Fang.
Afiliação
  • Wang Y; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Jiang C; Department of Internal Medicine, Foshan First People's Hospital, Foshan, China.
  • Tang M; Cancer Neurobiology Group, School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
  • Li H; School of Medicine & Public Health, The University of Newcastle, Callaghan, NSW, Australia.
  • Zhao C; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Zhao M; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Zhang Y; Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Li X; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Mi J; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Shen H; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Wang Z; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
  • Su F; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Quant Imaging Med Surg ; 13(8): 5362-5368, 2023 Aug 01.
Article em En | MEDLINE | ID: mdl-37581042

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article